RemedyRepack Inc. recalls Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282
Recalled May 4, 2022 · FDA recall D-0788-2022 · RemedyRepack
Hazard
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits. · FDA Class II
Units
433/30 count blister cards, 33/60 count blister cards
Sold at
Product was distributed to customers in AK and PA.
Description
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Product
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.
Manufacturer(s)
RemedyRepack Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →